UBS Group
ORGN

UBS Group’s Origin Materials ORGN Stock Holding History

UBS Group’s Portfolio ORGN Stock Details ORGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.62K Sell
5,677
-6,016
-51% -$9.79K ﹤0.01% 8913
2026
Q1 		$26.7K Buy
11,693
+8,224
+237% +$40.3K ﹤0.01% 7763
2025
Q4 		$22.1K Buy
3,469
+2,652
+325% +$38.7K ﹤0.01% 7714
2025
Q3 		$12.7K Sell
817
-31,197
-97% -$579K ﹤0.01% 8429
2025
Q2 		$464K Buy
32,014
+16,415
+105% +$278K ﹤0.01% 6071
2025
Q1 		$311K Buy
15,599
+14,924
+2,211% +$410K ﹤0.01% 6218
2024
Q4 		$25.9K Buy
675
+631
+1,434% +$24K ﹤0.01% 7719
2024
Q3 		$2.02K Sell
44
-286
-87% -$10.4K ﹤0.01% 8516
2024
Q2 		$8.91K Sell
330
-4,345
-93% -$116K ﹤0.01% 7772
2024
Q1 		$71.5K Sell
4,675
-371
-7% -$6.44K ﹤0.01% 6359
2023
Q4 		$127K Sell
5,046
-4,001
-44% -$115K ﹤0.01% 6049
2023
Q3 		$347K Buy
9,047
+571
+7% +$44.8K ﹤0.01% 4938
2023
Q2 		$1.08M Buy
8,476
+203
+2% +$26.1K ﹤0.01% 4164
2023
Q1 		$1.06M Buy
8,273
+1,129
+16% +$167K ﹤0.01% 4052
2022
Q4 		$988K Buy
7,144
+997
+16% +$159K ﹤0.01% 4085
2022
Q3 		$951K Sell
6,147
-180
-3% -$31.9K ﹤0.01% 3787
2022
Q2 		$972K Buy
6,327
+1,413
+29% +$269K ﹤0.01% 3765
2022
Q1 		$970K Buy
4,914
+1,053
+27% +$184K ﹤0.01% 4131
2021
Q4 		$747K Sell
3,861
-594
-13% -$118K ﹤0.01% 4640
2021
Q3 		$910K Sell
4,455
-1,161
-21% -$239K ﹤0.01% 4268
2021
Q2 		$1.38M Buy
5,616
+5,160
+1,132% +$1.54M ﹤0.01% 3907
2021
Q1 		$138K Sell
456
-418
-48% -$138K ﹤0.01% 5719
2020
Q4 		$279K Buy
+874
New +$261K ﹤0.01% 5019

Other funds holding ORGN

AWP
Accretive Wealth Partners Parsippany, New Jersey $412M AUM 15.82% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
RC
Rangeley Capital New Canaan, Connecticut $109M AUM 97.13% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
LDNAM
Lepercq De Neuflize Asset Management New York $158M AUM 20.61% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

UBS Group's ORGN Position: Q2 2026 in Review

UBS Group reduced its Origin Materials (ORGN) stake by 51% in Q2 2026, selling an estimated $9.79K and leaving 5,677 shares worth $5.62K. The position accounts for ﹤0.01% of the portfolio, ranked #8913.

UBS Group first reported a position in ORGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.38M in Q2 2021. 38 funds tracked by Wall St. Rank hold ORGN as of Q2 2026.

  • UBS Group held 5,677 shares of Origin Materials worth $5.62K as of Q2 2026.
  • UBS Group sold 6,016 Origin Materials shares in Q2 2026, an estimated $9.79K.
  • Origin Materials made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #8913 holding.
  • UBS Group first reported a position in Origin Materials in Q4 2020 and has held it in 23 quarters since.
  • UBS Group's Origin Materials position peaked at $1.38M in Q2 2021.
  • 38 funds tracked by Wall St. Rank held Origin Materials as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.